Key details
Sponsor
Taizhou Mabtech Pharmaceutical Co.,Ltd
Enrollment target
~392 participants
Primary completion
April 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
15 Years – 75 Years
Last updated November 2025